Genetic blueprint may guide smarter cancer therapy
NCT ID NCT05032092
First seen Nov 21, 2025 · Last updated May 13, 2026 · Updated 23 times
Summary
This study looks at whether analyzing the genes of a tumor (from a tissue sample or a blood draw) can help doctors pick a more effective treatment for people with advanced solid cancers that have stopped responding to standard therapies. About 235 participants will have their tumor genes mapped, and researchers will compare how long their cancer stays under control on the gene-matched treatment versus their previous therapy. The goal is to see if this personalized approach can slow cancer growth.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Landesklinikum Amstetten
Amstetten, 3300, Austria
-
Landeskrankenhaus Feldkirch, Department of Internal Medicine II
Feldkirch, Vorarlberg, 6807, Austria
-
Medical University of Graz
Graz, 8036, Austria
-
Medical University of Innsbruck, Department of Hematology and Oncology
Innsbruck, Tyrol, 6020, Austria
-
Ordensklinikum Linz
Linz, Upper Austria, 4010, Austria
-
University Hospital Salzburg, Department of Internal Medicine III
Salzburg, State of Salzburg, 5020, Austria
Conditions
Explore the condition pages connected to this study.